Cargando…
Maintenance of head and neck tumor on-chip: gateway to personalized treatment?
AIM: Head and neck squamous cell carcinomas (HNSCC) are solid tumors with low overall survival (40–60%). In a move toward personalized medicine, maintenance of tumor biopsies in microfluidic tissue culture devices is being developed. METHODOLOGY/RESULTS: HNSCC (n = 15) was dissected (5–10 mg) and ei...
Autores principales: | Bower, Ruth, Green, Victoria L, Kuvshinova, Elena, Kuvshinov, Dmitriy, Karsai, Laszlo, Crank, Stephen T, Stafford, Nicholas D, Greenman, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481812/ https://www.ncbi.nlm.nih.gov/pubmed/28670466 http://dx.doi.org/10.4155/fsoa-2016-0089 |
Ejemplares similares
-
A patient tumour-on-a-chip system for personalised investigation of radiotherapy based treatment regimens
por: Kennedy, R., et al.
Publicado: (2019) -
A novel microfluidic device capable of maintaining functional thyroid carcinoma specimens ex vivo provides a new drug screening platform
por: Riley, Andrew, et al.
Publicado: (2019) -
Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridisation
por: Ashman, J N E, et al.
Publicado: (2003) -
Can a genetic signature for metastatic head and neck squamous cell carcinoma be characterised by comparative genomic hybridisation?
por: Patmore, H S, et al.
Publicado: (2004) -
Can a genetic signature for metastatic head and neck squamous cell carcinoma be characterised by comparative genomic hybridisation?
por: Patmore, H S, et al.
Publicado: (2004)